Back
5 June 2025
The ITA reports that the athlete Abdalla Hisham ABDEL GAWAD has agreed¹ to the consequences imposed for his anti-doping rule violation (ADRV).
The athlete provided a sample on 29 January 2023 during an in-competition anti-doping control at the Karate 1 – Premier League held in Cairo (Egypt). After analysis by a World Anti-Doping Agency (“WADA”)-accredited laboratory, the sample returned an adverse analytical finding for dexamethasone.²
Dexamethasone is prohibited under the WADA Prohibited List in the category S9. Glucocorticoids. It is prohibited in-competition only and is classified as a specified . Dexamethasone is used to treat injuries and/or to manage chronic inflammatory conditions.
The athlete did not challenge his ADRV and agreed with the consequences proposed by the ITA, namely a period of ineligibility of two years from 9 March 2023 until 8 March 2025 and the disqualification of his competitive results from 29 January 2023 onwards.
The relevant stakeholders, namely the World Anti-Doping Agency and the Egypt National Anti-doping Organization, have a right to appeal the consequences imposed before the appeals division of the Court of Arbitration for Sport.
The ITA will not comment further on this case.
¹ Athletes have the right to choose not to have their case referred to a hearing panel. In these instances, the anti-doping organisation will assess the athlete’s case file and establish the applicable consequences pursuant to the anti-doping rules and the athlete will have the right to accept the proposed consequences. If the athlete refuses the proposed consequences, the case is transferred to a hearing panel. This resolution mechanism is provided for in articles 8.3.1 and 8.3.3 of the WKF anti-doping rules and 8.3 of the World Anti-Doping Code and is commonly referred to as an agreement on consequences and is deemed an WKF/ITA decision. The athlete’s National Anti-Doping Organisation and the World Anti-Doping Agency have the right to appeal the agreement on consequences before the competent appeal body.
² A report from a WADA-accredited laboratory that, consistent with the International Standard for Laboratories, establishes in a sample the presence of a prohibited substance or its metabolites or markers or evidence of the use of a prohibited method.
